• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.一名感染新冠病毒的儿童出现高炎症综合征，经静脉注射免疫球蛋白和托珠单抗成功治愈。
Indian Pediatr. 2020 Jul 15;57(7):681-683. doi: 10.1007/s13312-020-1901-z. Epub 2020 May 10.
2
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19.新冠病毒肺炎（COVID-19）感染年轻男性患者的心源性休克和高炎症综合征
Circ Heart Fail. 2020 Oct;13(10):e007485. doi: 10.1161/CIRCHEARTFAILURE.120.007485. Epub 2020 Aug 26.
3
Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.儿童 COVID-19 患者和多系统炎症综合征的严重临床谱和高死亡率。
Clinics (Sao Paulo). 2020;75:e2209. doi: 10.6061/clinics/2020/e2209. Epub 2020 Aug 19.
4
COVID-19-Associated Pediatric Multisystem Inflammatory Syndrome.与新冠病毒相关的儿童多系统炎症综合征
J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):407-408. doi: 10.1093/jpids/piaa061.
5
Multisystem inflammatory syndrome in children in South Africa.南非儿童多系统炎症综合征
Lancet Child Adolesc Health. 2020 Oct;4(10):e38. doi: 10.1016/S2352-4642(20)30272-8. Epub 2020 Aug 21.
6
COVID-19 in patients with myasthenia gravis.COVID-19 与重症肌无力。
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
7
Insights into pediatric multi-system inflammatory syndrome and COVID-19.儿童多系统炎症综合征与新型冠状病毒肺炎的见解
Clin Chim Acta. 2020 Nov;510:121-122. doi: 10.1016/j.cca.2020.07.025. Epub 2020 Jul 14.
8
COVID-19 in a Patient With Rheumatoid Arthritis During Tocilizumab Treatment.托珠单抗治疗期间类风湿关节炎患者的COVID-19感染
J Clin Rheumatol. 2020 Sep;26(6):240-241. doi: 10.1097/RHU.0000000000001576.
9
Clinical findings in a patient with haemophilia A affected by COVID-19.一名甲型血友病患者感染新型冠状病毒肺炎的临床发现。
Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13.
10
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.COVID-19 患儿的过度炎症反应和免疫调节药物的作用。
Paediatr Respir Rev. 2020 Sep;35:81-87. doi: 10.1016/j.prrv.2020.07.003. Epub 2020 Jul 29.

引用本文的文献

1
[Multisystemic inflammatory syndrome in children with COVID-19: a rheumatology perspective].[新型冠状病毒肺炎患儿的多系统炎症综合征：风湿病学视角]
Rev Colomb Reumatol. 2021 Oct-Dec;28(4):289-299. doi: 10.1016/j.rcreu.2020.09.005. Epub 2020 Oct 17.
2
Multisystem Inflammatory Syndrome in Children (MIS-C) in a Low-income Country: What Treatment Should be Adopted in Case of a Lack of Immunoglobulin?儿童多系统炎症综合征（MIS-C）在低收入国家：如果缺乏免疫球蛋白，应采用何种治疗方法？
Rev Recent Clin Trials. 2024;19(2):150-157. doi: 10.2174/0115748871257131231204114803.
3
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.长期新冠：并发症、潜在机制及治疗策略
Arch Microbiol Immunol. 2023;7(2):36-61. Epub 2023 May 9.
4
Cardiological Monitoring - A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature.心脏监测——与 COVID-19 相关的儿童炎症性多系统综合征预后的基石：一例病例报告及文献综述
J Crit Care Med (Targu Mures). 2022 Nov 12;8(4):273-278. doi: 10.2478/jccm-2022-0022. eCollection 2022 Oct.
5
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience.资源有限环境下儿童多系统炎症综合征（MIS-C）的管理：肯尼亚经验。
Pediatr Rheumatol Online J. 2022 Dec 5;20(1):110. doi: 10.1186/s12969-022-00773-9.
6
Long-Term Cardiovascular Outcome in Children with MIS-C Linked to SARS-CoV-2 Infection-An Italian Multicenter Experience.与SARS-CoV-2感染相关的儿童多系统炎症综合征的长期心血管结局——一项意大利多中心经验
Biology (Basel). 2022 Oct 8;11(10):1474. doi: 10.3390/biology11101474.
7
Management of Multisystem Inflammatory Syndrome in Children (MIS-C) in resource limited settings: The Kenyan Experience.资源有限环境下儿童多系统炎症综合征（MIS-C）的管理：肯尼亚经验
Res Sq. 2022 Aug 17:rs.3.rs-1951206. doi: 10.21203/rs.3.rs-1951206/v1.
8
Contributing factors to pediatric COVID-19 and MIS-C during the initial waves: A systematic review of 92 case reports.第一波疫情期间儿童新冠病毒感染及儿童多系统炎症综合征的促成因素：对92例病例报告的系统评价
Ann Med Surg (Lond). 2022 Sep;81:104227. doi: 10.1016/j.amsu.2022.104227. Epub 2022 Jul 31.
9
Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19.川崎病患儿与新冠病毒病患儿实验室数据的比较
Children (Basel). 2022 Apr 28;9(5):638. doi: 10.3390/children9050638.
10
Epidemiology, Clinical Features, and Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C) and Adolescents-a Live Systematic Review and Meta-analysis.儿童和青少年多系统炎症综合征（MIS-C）的流行病学、临床特征及转归——一项实时系统评价与Meta分析
Curr Pediatr Rep. 2022;10(2):19-30. doi: 10.1007/s40124-022-00264-1. Epub 2022 May 6.

本文引用的文献

1
Hyperinflammatory shock in children during COVID-19 pandemic.新冠疫情期间儿童的高炎症性休克
Lancet. 2020 May 23;395(10237):1607-1608. doi: 10.1016/S0140-6736(20)31094-1. Epub 2020 May 7.
2
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
3
Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not.儿童 2019 冠状病毒病（COVID-19）：迄今已知和未知情况。
Indian Pediatr. 2020 May 15;57(5):435-442. doi: 10.1007/s13312-020-1819-5. Epub 2020 Apr 9.
4
Tocilizumab treatment in COVID-19: A single center experience.托珠单抗治疗 COVID-19：单中心经验。
J Med Virol. 2020 Jul;92(7):814-818. doi: 10.1002/jmv.25801. Epub 2020 Apr 15.
5
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019（COVID-19）患者中的应用：来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.

Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab.

作者信息

Balasubramanian S, Nagendran T M, Ramachandran B, Ramanan A V

机构信息

Department of Pediatrics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.

Pediatric Intensive Care Unit, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.

出版信息

Indian Pediatr. 2020 Jul 15;57(7):681-683. doi: 10.1007/s13312-020-1901-z. Epub 2020 May 10.

DOI:10.1007/s13312-020-1901-z
PMID:32393681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7387261/
Abstract
摘要